Thu, 21 Aug 2008 02:24:38 BST CiteULike: wandall Elliott http://www.citeulike.org/user/wandall/author/Elliott CiteULike.org en-gb Copyright © 2004-2008 citeulike.org http://www.citeulike.org/user/wandall/article/2203908 <i>Accountability in Research, Vol. 15, No. 1. (2008), pp. 1-29.</i><br /><br />This article argues that the three major elements of typical university conflict-of-interest (COI) policies (i.e., disclosure, management, and elimination of conflicts via divestiture or recusal) are likely to be insufficient for screening out many worrisome influences of financial COIs. Current psychological research challenges the effectiveness of disclosure, management plans are unlikely to address the wide range of ways that financial COIs can influence scientific judgment, and it is often impractical to eliminate conflicts. Identifying the limits of these policies highlights the importance of considering alternative strategies, such as encouraging more independently funded research, in order to maintain the integrity of science. Scientific Judgment and the Limits of Conflict-of-Interest Policies Kevin Elliott doi:10.1080/08989620701783725 Accountability in Research, Vol. 15, No. 1. (2008), pp. 1-29. 2008-01-07T14:28:15-00:00 2008 Accountability in Research 15 1 1 29 Taylor & Francis bias conflict_of_interest judgement judgment http://www.citeulike.org/user/wandall/article/2145256 <i>Philosophy of Science, Vol. 73, No. 5. (December 2006), pp. 790-802.</i> A Novel Account of Scientific Anomaly: Help for the Dispute over Low‐Dose Biochemical Effects Kevin Elliott Philosophy of Science, Vol. 73, No. 5. (December 2006), pp. 790-802. 2007-12-19T12:36:33-00:00 2006 Philosophy of Science 73 5 790 802 anomaly chemicals controversy hormesis low-dose value_judgment http://www.citeulike.org/user/wandall/article/1267565 <i>Perspect Biol Med, Vol. 50, No. 1. (2007), pp. 18-31.</i><br /><br />The use of ghostwriters by industry is subject to increasing public attention and scrutiny. This article addresses the practice and ethics of scientific ghostwriting. We focus on the type of ghostwriting that involves a pharmaceutical company hiring a medical education and communications company to write a paper favorable of their product, who then hires a well-known academic to publish it under his or her name without disclosing the paper's true origins. We argue that this practice is harmful both to the public and to the institutions of science and that it is not justified by an analogy to accepted scientific authorship practices. Finally, we consider ways to discourage the practice. Ghost marketing: pharmaceutical companies and ghostwritten journal articles. B Moffatt C Elliott doi:10.1353/pbm.2007.0009 Perspect Biol Med, Vol. 50, No. 1. (2007), pp. 18-31. 2007-04-30T09:28:26-00:00 2007 Perspect Biol Med 0031-5982 50 1 18 31 ghost_authorship publication